| UniProt ID | OAS1_HUMAN | |
|---|---|---|
| UniProt AC | P00973 | |
| Protein Name | 2'-5'-oligoadenylate synthase 1 | |
| Gene Name | OAS1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 400 | |
| Subcellular Localization | Cytoplasm . Mitochondrion . Nucleus . Microsome . Endoplasmic reticulum . Secreted. Associated with different subcellular fractions such as mitochondrial, nuclear, and rough/smooth microsomal fractions. | |
| Protein Description | Interferon-induced, dsRNA-activated antiviral enzyme which plays a critical role in cellular innate antiviral response. In addition, it may also play a role in other cellular processes such as apoptosis, cell growth, differentiation and gene regulation. Synthesizes higher oligomers of 2'-5'-oligoadenylates (2-5A) from ATP which then bind to the inactive monomeric form of ribonuclease L (RNase L) leading to its dimerization and subsequent activation. Activation of RNase L leads to degradation of cellular as well as viral RNA, resulting in the inhibition of protein synthesis, thus terminating viral replication. Can mediate the antiviral effect via the classical RNase L-dependent pathway or an alternative antiviral pathway independent of RNase L. The secreted form displays antiviral effect against vesicular stomatitis virus (VSV), herpes simplex virus type 2 (HSV-2), and encephalomyocarditis virus (EMCV) and stimulates the alternative antiviral pathway independent of RNase L.. | |
| Protein Sequence | MMDLRNTPAKSLDKFIEDYLLPDTCFRMQINHAIDIICGFLKERCFRGSSYPVCVSKVVKGGSSGKGTTLRGRSDADLVVFLSPLTTFQDQLNRRGEFIQEIRRQLEACQRERAFSVKFEVQAPRWGNPRALSFVLSSLQLGEGVEFDVLPAFDALGQLTGGYKPNPQIYVKLIEECTDLQKEGEFSTCFTELQRDFLKQRPTKLKSLIRLVKHWYQNCKKKLGKLPPQYALELLTVYAWERGSMKTHFNTAQGFRTVLELVINYQQLCIYWTKYYDFKNPIIEKYLRRQLTKPRPVILDPADPTGNLGGGDPKGWRQLAQEAEAWLNYPCFKNWDGSPVSSWILLAESNSADDETDDPRRYQKYGYIGTHEYPHFSHRPSTLQAASTPQAEEDWTCTIL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 10 | Ubiquitination | DLRNTPAKSLDKFIE CCCCCCCHHHHHHHH | 53.40 | 29967540 | |
| 19 | Phosphorylation | LDKFIEDYLLPDTCF HHHHHHHHCCCCHHH | 9.43 | 27259358 | |
| 42 | Acetylation | DIICGFLKERCFRGS HHHHHHHHHHHCCCC | 40.63 | 26051181 | |
| 49 | Phosphorylation | KERCFRGSSYPVCVS HHHHCCCCCCCEEEE | 23.57 | 30108239 | |
| 50 | Phosphorylation | ERCFRGSSYPVCVSK HHHCCCCCCCEEEEE | 35.96 | 26657352 | |
| 50 (in isoform 3) | Phosphorylation | - | 35.96 | 24719451 | |
| 51 | Phosphorylation | RCFRGSSYPVCVSKV HHCCCCCCCEEEEEE | 11.03 | 23312004 | |
| 116 (in isoform 3) | Phosphorylation | - | 24.34 | 24719451 | |
| 116 | Phosphorylation | CQRERAFSVKFEVQA HHHHCCCEEEEEEEC | 24.34 | 24719451 | |
| 182 | Ubiquitination | EECTDLQKEGEFSTC HHHCHHHHCCCHHHH | 75.00 | 29967540 | |
| 199 | Ubiquitination | ELQRDFLKQRPTKLK HHHHHHHHHCCHHHH | 44.23 | 29967540 | |
| 207 | Phosphorylation | QRPTKLKSLIRLVKH HCCHHHHHHHHHHHH | 39.19 | 24719451 | |
| 213 | Ubiquitination | KSLIRLVKHWYQNCK HHHHHHHHHHHHHHH | 32.77 | 29967540 | |
| 220 | Ubiquitination | KHWYQNCKKKLGKLP HHHHHHHHHHHCCCC | 61.57 | 29967540 | |
| 271 | Phosphorylation | NYQQLCIYWTKYYDF CHHHHHHHHHHHCCC | 13.16 | 18083107 | |
| 279 | Ubiquitination | WTKYYDFKNPIIEKY HHHHCCCCCHHHHHH | 59.94 | 33845483 | |
| 285 | Ubiquitination | FKNPIIEKYLRRQLT CCCHHHHHHHHHHCC | 38.89 | 33845483 | |
| 314 | Ubiquitination | NLGGGDPKGWRQLAQ CCCCCCHHHHHHHHH | 75.69 | 29967540 | |
| 338 | Phosphorylation | CFKNWDGSPVSSWIL CCCCCCCCCCEEEEE | 21.47 | - | |
| 338 (in isoform 2) | Phosphorylation | - | 21.47 | 25159151 | |
| 341 | Phosphorylation | NWDGSPVSSWILLAE CCCCCCCEEEEEEEE | 24.28 | 23090842 | |
| 342 | Phosphorylation | WDGSPVSSWILLAES CCCCCCEEEEEEEEC | 20.54 | 23090842 | |
| 349 | Phosphorylation | SWILLAESNSADDET EEEEEEECCCCCCCC | 30.40 | 23090842 | |
| 351 | Phosphorylation | ILLAESNSADDETDD EEEEECCCCCCCCCC | 42.21 | 23090842 | |
| 356 | Phosphorylation | SNSADDETDDPRRYQ CCCCCCCCCCHHHHH | 53.34 | 23090842 | |
| 362 | Phosphorylation | ETDDPRRYQKYGYIG CCCCHHHHHHHCEEE | 15.61 | - | |
| 367 | Phosphorylation | RRYQKYGYIGTHEYP HHHHHHCEEECCCCC | 7.96 | 22461510 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of OAS1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of OAS1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of OAS1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ANM6_HUMAN | PRMT6 | physical | 23455924 | |
| BUD23_HUMAN | WBSCR22 | physical | 21988832 | |
| RL30_HUMAN | RPL30 | physical | 21988832 | |
| TRI27_HUMAN | TRIM27 | physical | 25416956 | |
| EXOC5_HUMAN | EXOC5 | physical | 25416956 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...